Cargando…

The Role of Biological Rhythms in New Drug Formulations to Cross the Brain Barriers

For brain protection, the blood–brain barrier and blood–cerebrospinal fluid barrier limit the traffic of molecules between blood and brain tissue and between blood and cerebrospinal fluid, respectively. Besides their protective function, brain barriers also limit the passage of therapeutic drugs to...

Descripción completa

Detalles Bibliográficos
Autores principales: Mineiro, Rafael, Albuquerque, Tânia, Neves, Ana Raquel, Santos, Cecília R. A., Costa, Diana, Quintela, Telma
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10454916/
https://www.ncbi.nlm.nih.gov/pubmed/37628722
http://dx.doi.org/10.3390/ijms241612541
_version_ 1785096318761304064
author Mineiro, Rafael
Albuquerque, Tânia
Neves, Ana Raquel
Santos, Cecília R. A.
Costa, Diana
Quintela, Telma
author_facet Mineiro, Rafael
Albuquerque, Tânia
Neves, Ana Raquel
Santos, Cecília R. A.
Costa, Diana
Quintela, Telma
author_sort Mineiro, Rafael
collection PubMed
description For brain protection, the blood–brain barrier and blood–cerebrospinal fluid barrier limit the traffic of molecules between blood and brain tissue and between blood and cerebrospinal fluid, respectively. Besides their protective function, brain barriers also limit the passage of therapeutic drugs to the brain, which constitutes a great challenge for the development of therapeutic strategies for brain disorders. This problem has led to the emergence of novel strategies to treat neurological disorders, like the development of nanoformulations to deliver therapeutic agents to the brain. Recently, functional molecular clocks have been identified in the blood–brain barrier and in the blood–cerebrospinal fluid barrier. In fact, circadian rhythms in physiological functions related to drug disposition were also described in brain barriers. This opens the possibility for chronobiological approaches that aim to use time to improve drug efficacy and safety. The conjugation of nanoformulations with chronobiology for neurological disorders is still unexplored. Facing this, here, we reviewed the circadian rhythms in brain barriers, the nanoformulations studied to deliver drugs to the brain, and the nanoformulations with the potential to be conjugated with a chronobiological approach to therapeutic strategies for the brain.
format Online
Article
Text
id pubmed-10454916
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-104549162023-08-26 The Role of Biological Rhythms in New Drug Formulations to Cross the Brain Barriers Mineiro, Rafael Albuquerque, Tânia Neves, Ana Raquel Santos, Cecília R. A. Costa, Diana Quintela, Telma Int J Mol Sci Review For brain protection, the blood–brain barrier and blood–cerebrospinal fluid barrier limit the traffic of molecules between blood and brain tissue and between blood and cerebrospinal fluid, respectively. Besides their protective function, brain barriers also limit the passage of therapeutic drugs to the brain, which constitutes a great challenge for the development of therapeutic strategies for brain disorders. This problem has led to the emergence of novel strategies to treat neurological disorders, like the development of nanoformulations to deliver therapeutic agents to the brain. Recently, functional molecular clocks have been identified in the blood–brain barrier and in the blood–cerebrospinal fluid barrier. In fact, circadian rhythms in physiological functions related to drug disposition were also described in brain barriers. This opens the possibility for chronobiological approaches that aim to use time to improve drug efficacy and safety. The conjugation of nanoformulations with chronobiology for neurological disorders is still unexplored. Facing this, here, we reviewed the circadian rhythms in brain barriers, the nanoformulations studied to deliver drugs to the brain, and the nanoformulations with the potential to be conjugated with a chronobiological approach to therapeutic strategies for the brain. MDPI 2023-08-08 /pmc/articles/PMC10454916/ /pubmed/37628722 http://dx.doi.org/10.3390/ijms241612541 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Mineiro, Rafael
Albuquerque, Tânia
Neves, Ana Raquel
Santos, Cecília R. A.
Costa, Diana
Quintela, Telma
The Role of Biological Rhythms in New Drug Formulations to Cross the Brain Barriers
title The Role of Biological Rhythms in New Drug Formulations to Cross the Brain Barriers
title_full The Role of Biological Rhythms in New Drug Formulations to Cross the Brain Barriers
title_fullStr The Role of Biological Rhythms in New Drug Formulations to Cross the Brain Barriers
title_full_unstemmed The Role of Biological Rhythms in New Drug Formulations to Cross the Brain Barriers
title_short The Role of Biological Rhythms in New Drug Formulations to Cross the Brain Barriers
title_sort role of biological rhythms in new drug formulations to cross the brain barriers
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10454916/
https://www.ncbi.nlm.nih.gov/pubmed/37628722
http://dx.doi.org/10.3390/ijms241612541
work_keys_str_mv AT mineirorafael theroleofbiologicalrhythmsinnewdrugformulationstocrossthebrainbarriers
AT albuquerquetania theroleofbiologicalrhythmsinnewdrugformulationstocrossthebrainbarriers
AT nevesanaraquel theroleofbiologicalrhythmsinnewdrugformulationstocrossthebrainbarriers
AT santosceciliara theroleofbiologicalrhythmsinnewdrugformulationstocrossthebrainbarriers
AT costadiana theroleofbiologicalrhythmsinnewdrugformulationstocrossthebrainbarriers
AT quintelatelma theroleofbiologicalrhythmsinnewdrugformulationstocrossthebrainbarriers
AT mineirorafael roleofbiologicalrhythmsinnewdrugformulationstocrossthebrainbarriers
AT albuquerquetania roleofbiologicalrhythmsinnewdrugformulationstocrossthebrainbarriers
AT nevesanaraquel roleofbiologicalrhythmsinnewdrugformulationstocrossthebrainbarriers
AT santosceciliara roleofbiologicalrhythmsinnewdrugformulationstocrossthebrainbarriers
AT costadiana roleofbiologicalrhythmsinnewdrugformulationstocrossthebrainbarriers
AT quintelatelma roleofbiologicalrhythmsinnewdrugformulationstocrossthebrainbarriers